Abbott Laboratories buy JPMorgan Chase & Co.
Start price
20.04.23
/
50%
€101.24
Target price
20.04.24
€111.01
Performance (%)
-0.75%
End price
21.04.24
€100.48
Summary
This prediction ended on 21.04.24 with a price of €100.48. The BUY prediction by JPMorgan_Chase___Co_ for Abbott Laboratories closed nearly unchanged. Dividends of €1.96 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -0.447% | -0.447% | -1.055% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at JPMorgan Chase & Co. from $118.00 to $122.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten